United States · FDA National Drug Code directory
HYPERRAB S/D
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13533-618_58aefdbd-27e0-46a7-905e-aefb089a92b2
- Product NDC
- 13533-618
- Form
- INJECTION
- Composition / generic term
- RABIES IMMUNE GLOBULIN (HUMAN)
- Labeler
- GRIFOLS USA, LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 19960814
- Source listing expiry
- 20261231
Source-listed ingredients
- HUMAN RABIES VIRUS IMMUNE GLOBULIN — 150 [iU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (13533-618-02) / 2 mL in 1 VIAL, GLASS (13533-618-20) · 13533-618-02
- 1 VIAL in 1 CARTON (13533-618-10) / 10 mL in 1 VIAL (13533-618-11) · 13533-618-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →